KNSA · Kiniksa Pharmaceuticals International, plc · Documents
$84.00
+4.52 (+5.69%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$12.40B
Shares
156.05M
Volume · Oct 20
1.23M
Avg daily vol (3M)
597.48K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-06-07 | 2023-06-06 | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| 8-K | — | 2023-05-02 | — | |
| DEF 14A | — | 2023-04-27 | 2023-06-06 | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 10-K | — | 2023-03-02 | 2022-12-31 | |
| 8-K | — | 2023-02-28 | — | |
| 8-K | — | 2023-01-09 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-01 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-08-03 | 2022-08-02 | |
| 8-K | — | 2022-06-30 | 2022-06-29 | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| 8-K | — | 2022-05-03 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-29 | |
| 10-K | — | 2022-02-24 | 2021-12-31 | |
| 8-K | — | 2022-02-22 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2022-01-03 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-11-01 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-08-03 | — | |
| 8-K | — | 2021-07-06 | 2021-06-29 | |
| 8-K | — | 2021-05-12 | 2021-05-06 | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-04 | — | |
| DEF 14A | — | 2021-04-28 | 2021-06-29 | |
| 8-K | — | 2021-04-28 | 2021-04-26 | |
| 8-K | — | 2021-03-03 | 2021-03-01 | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-02-23 | — | |
| 8-K | — | 2021-01-11 | — | |
| 8-K | — | 2020-12-22 | 2020-12-16 | |
| 8-K | — | 2020-11-10 | 2020-11-06 | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-10-26 | 2020-10-23 | |
| 10-Q | — | 2020-08-04 | 2020-06-30 | |
| 8-K | — | 2020-07-30 | — | |
| 8-K | — | 2020-07-28 | 2020-07-25 | |
| 8-K | — | 2020-07-24 | 2020-07-20 | |
| 8-K | — | 2020-07-15 | 2020-07-09 | |
| 8-K | — | 2020-07-07 | 2020-06-30 | |
| 8-K | — | 2020-06-29 | — | |
| 8-K | — | 2020-05-18 | 2020-05-13 | |
| 10-Q | — | 2020-05-04 | 2020-03-31 | |
| 8-K | — | 2020-04-28 | — | |
| DEF 14A | — | 2020-04-28 | 2020-06-30 |
Showing 51–100 of 105 filings
Key facts
CIK
1730430
CUSIP
G52694109
13F (30d)
24 filings
24 filers
Visit website
Investor relations